Factors predict prolonged wait time and longer duration of radiotherapy in patients with nasopharyngeal carcinoma: A multilevel analysis

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Chen, Po Chun ^a   Yang, Ching Chieh ^b   Wu, Cheng Jung ^c   Liu, Wen Shan ^c   Huang, Wei Lun ^c   Lee, Ching Chih ^d,e  

^a PINGTUNG CHRISTIAN HOSPITAL   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d Taichung Tzu Chi Hospital   (Taiwan)

^e TZU CHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CHARLSON COMORBIDITY INDEX; COMORBIDITY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DEMOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GEOGRAPHY; HEALTH CARE DISPARITY; HOSPITAL ADMISSION; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; TAIWAN; TREATMENT DURATION; URBANIZATION; WATCHFUL WAITING; ADOLESCENT; AGED; CHEMORADIOTHERAPY; CHILD; INFANT; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEWBORN; PRESCHOOL CHILD; RADIATION DOSE FRACTIONATION; TIME TO TREATMENT; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHEMORADIOTHERAPY; CHILD; CHILD, PRESCHOOL; DOSE FRACTIONATION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; TIME-TO-TREATMENT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84908003874     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109930     Document Type: Article

References (23)

1. Taiwan Cancer Registry Annual Report, 2001. (2004) Department of Health, The Executive Yuan, Republic of China. Available: http://tcr.cph.ntu.edu.tw/main.php?Page=N2. Accessed 17 March 2014.
2. Wei WI, Sham JS (2005) Nasopharyngeal carcinoma. Lancet 365: 2041-2054.
3. Zhang L, Zhao C, Ghimire B, Hong MH, Liu Q, et al. (2010) The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase III randomized trials. BMC Cancer 10: 558.
4. Lin JC, Jan JS, Hsu CY, Liang WM, Jiang RS, et al. (2003) Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol 21: 631-637.
5. Chan AT, Teo PM, Ngan RK, Leung TW, Lau WH, et al. (2002) Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol 20: 2038-2044.
6. Huang J, Barbera L, Brouwers M, Browman G, Mackillop WJ (2003) Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 21: 555-563.
7. Fortin A, Bairati I, Albert M, Moore L, Allard J, et al. (2002) Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapy. Int J Radiat Oncol Biol Phys 52: 929-936.
8. Cannon DM, Geye HM, Hartig GK, Traynor AM, Hoang T, et al. (2013) Increased local failure risk with prolonged radiation treatment time in head and neck cancer treated with concurrent chemotherapy. Head Neck 36: 1120-1125.
9. Chang JT, See LC, Liao CT, Chen LH, Leung WM, et al. (1998) Early stage nasopharyngeal carcinoma: radiotherapy dose and time factors in tumor control. Jpn J Clin Oncol 28: 207-213.
10. Chang TS, Chang CM, Hsu TW, Lin YS, Lai NS, et al. (2013) The combined effect of individual and neighborhood socioeconomic status on nasopharyngeal cancer survival. PLoS One 8:e73889.
11. Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45: 613-619.
12. Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML (2011) Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 20: 236-242.
13. Round CE, Williams MV, Mee T, Kirkby NF, Cooper T, et al. (2013) Radiotherapy demand and activity in England 2006-2020. Clin Oncol (R Coll Radiol) 25: 522-530.
14. Abdel-Wahab M, Bourque JM, Pynda Y, Iżewska J, Van der Merwe D, et al. (2013) Status of radiotherapy resources in Africa: an International Atomic Energy Agency analysis. Lancet Oncol 14:e168-e175.
15. Paleri V, Wight RG, Silver CE, Haigentz M Jr, Takes RP, et al. (2010) Comorbidity in head and neck cancer: a critical appraisal and recommendations for practice. Oral Oncol 46: 712-719.
16. Baijal G, Gupta T, Hotwani C, Laskar SG, Budrukkar A, et al. (2012) Impact of comorbidity on therapeutic decision-making in head and neck cancer: audit from a comprehensive cancer center in India. Head Neck 34: 1251-1254.
17. Takahashi PY, Kiemele LJ, Chandra A, Cha SS, Targonski PV (2009) A retrospective cohort study of factors that affect healing in long-term care residents with chronic wounds. Ostomy Wound Manage 55: 32-37.
18. Bøje CR, Dalton SO, Primdahl H, Kristensen CA, Andersen E, et al. (2014) Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database. Radiother Oncol 110: 91-97.
19. Wu XC, Lund MJ, Kimmick GG, Richardson LC, Sabatino SA, et al. (2012) Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers. J Clin Oncol 30: 142-150.
20. Willems S, De Maesschalck S, Deveugele M, Derese A, De Maeseneer J, et al. (2005) Socio-economic status of the patient and doctor-patient communication: does it make a difference? Patient Educ Couns 56: 139-146.
21. Kwong DL, Sham JS, Chua DT, Choy DT, Au GK, et al. (1997) The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 39: 703-710.
22. Sher DJ, Posner MR, Tishler RB, Sarlis NJ, Haddad RI, et al. (2011) Relationship between radiation treatment time and overall survival after induction chemotherapy for locally advanced head-and-neck carcinoma: a subset analysis of TAX 324. Int J Radiat Oncol Biol Phys 81:e813-e818.
23. Kim TH, Ko YH, Lee MA, Kim BS, Chung SR, et al. (2008) Treatment outcome of cisplatin-based concurrent chemoradiotherapy in the patients with locally advanced nasopharyngeal cancer. Cancer Res Treat 40: 62-70.